P03.08 Pathological Analysis of Xenografts with Malignant Glioma After Anti-angiogenic Therapy

Introduction: Malignant gliomas are known to secrete high levels of vascular endothelial growth factor (VEGF). Bevacizumab, which is a monoclonal antibody to VEGF, has demonstrated convincing therapeutic benefits in patients with glioblastoma. However, several reports have shown that anti-VEGF thera...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Ishida, J., Kurozumi, K., Ichikawa, T., Shimizu, T., Otani, Y., Fujii, K., Tomita, Y., Hattori, Y., Date, I.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2017
Gaiak:
POSTER PRESENTATIONS
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5463698/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.123
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak